Clinical Trial Focus Small-to-mid sized CRO with emphasis on Phase II to IV trials and a strong pulmonary patient base. Potential upsell opportunities include expanding trial modalities, adding early feasibility studies, and offering site management services for sponsor programs seeking faster startup times.

Patient Recruitment Dedicated recruitment specialists and large local patient database indicate strong enrollment capabilities, especially for pulmonary-related studies. Sales angle: package recruitment acceleration services, patient retention programs, and access to diverse candidate pools for oncology, cardiovascular, or respiratory trials.

Operational Readiness Robust SOPs, HIPAA compliance, and centralized IRB support suggest reliable trial execution. Upsell risk management and regulatory concierge services, including remote monitoring readiness and audit-ready documentation bundles.

Facilities & Capabilities Comprehensive on-site testing and equipment (CPET, PFT, echocardiograms, labs, imaging, biobanking, -70C freezers) enable complex data collection. Cross-sell: integrated data capture, real-time analytics, and adaptive trial design support leveraging their bench and laboratory assets.

Growth & Partnerships Revenue range shows growth potential but remains lean; leverage proximity to a large local hospital and private monitoring spaces to pursue strategic partnerships, consortium studies, and investigator-initiated trials with pharma, biotech, and medical device sponsors.